These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
379 related items for PubMed ID: 26073741
1. Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension. Soon E, Crosby A, Southwood M, Yang P, Tajsic T, Toshner M, Appleby S, Shanahan CM, Bloch KD, Pepke-Zaba J, Upton P, Morrell NW. Am J Respir Crit Care Med; 2015 Oct 01; 192(7):859-72. PubMed ID: 26073741 [Abstract] [Full Text] [Related]
2. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Long L, MacLean MR, Jeffery TK, Morecroft I, Yang X, Rudarakanchana N, Southwood M, James V, Trembath RC, Morrell NW. Circ Res; 2006 Mar 31; 98(6):818-27. PubMed ID: 16497988 [Abstract] [Full Text] [Related]
4. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension. Tojais NF, Cao A, Lai YJ, Wang L, Chen PI, Alcazar MAA, de Jesus Perez VA, Hopper RK, Rhodes CJ, Bill MA, Sakai LY, Rabinovitch M. Arterioscler Thromb Vasc Biol; 2017 Aug 31; 37(8):1559-1569. PubMed ID: 28619995 [Abstract] [Full Text] [Related]
8. Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells. Yang J, Li X, Li Y, Southwood M, Ye L, Long L, Al-Lamki RS, Morrell NW. Am J Physiol Lung Cell Mol Physiol; 2013 Aug 15; 305(4):L312-21. PubMed ID: 23771884 [Abstract] [Full Text] [Related]
14. Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension. Yang J, Li X, Al-Lamki RS, Wu C, Weiss A, Berk J, Schermuly RT, Morrell NW. Arterioscler Thromb Vasc Biol; 2013 Jan 15; 33(1):34-42. PubMed ID: 23139294 [Abstract] [Full Text] [Related]
15. Endothelial BMPR2 Loss Drives a Proliferative Response to BMP (Bone Morphogenetic Protein) 9 via Prolonged Canonical Signaling. Theilmann AL, Hawke LG, Hilton LR, Whitford MKM, Cole DV, Mackeil JL, Dunham-Snary KJ, Mewburn J, James PD, Maurice DH, Archer SL, Ormiston ML. Arterioscler Thromb Vasc Biol; 2020 Nov 15; 40(11):2605-2618. PubMed ID: 32998516 [Abstract] [Full Text] [Related]
17. Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle. Hagen M, Fagan K, Steudel W, Carr M, Lane K, Rodman DM, West J. Am J Physiol Lung Cell Mol Physiol; 2007 Jun 15; 292(6):L1473-9. PubMed ID: 17322283 [Abstract] [Full Text] [Related]
18. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Atkinson C, Stewart S, Upton PD, Machado R, Thomson JR, Trembath RC, Morrell NW. Circulation; 2002 Apr 09; 105(14):1672-8. PubMed ID: 11940546 [Abstract] [Full Text] [Related]
19. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension. Maruyama H, Dewachter C, Belhaj A, Rondelet B, Sakai S, Remmelink M, Vachiery JL, Naeije R, Dewachter L. J Heart Lung Transplant; 2015 Mar 09; 34(3):468-78. PubMed ID: 25447587 [Abstract] [Full Text] [Related]
20. Impaired Interleukin-15 Signaling via BMPR2 Loss Drives Natural Killer Cell Deficiency and Pulmonary Hypertension. Hilton LR, Rätsep MT, VandenBroek MM, Jafri S, Laverty KJ, Mitchell M, Theilmann AL, Smart JA, Hawke LG, Moore SD, Renaud SJ, Soares MJ, Morrell NW, Ormiston ML. Hypertension; 2022 Nov 09; 79(11):2493-2504. PubMed ID: 36043416 [Abstract] [Full Text] [Related] Page: [Next] [New Search]